nature’s

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE…

8 months ago

24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Natures Toughest Fiber

DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial…

10 months ago

Nature’s Miracle Holding Inc. (“NMHI”), Datavault AI (“DVLT”) and Harrison Global Holdings Inc. (“BLMZ) Join Forces to Launch the X Club for the Global XRP Community

ONTARIO, Calif., Sept. 22, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) along with Datavault AI Inc.(Nasdaq: DVLT) and Harrison…

10 months ago